Biocon arm gets supplemental USFDA approval for autoimmune disease drug ...Middle East

Business Standard - Economy

Biocon Ltd on Tuesday said its subsidiary has received supplemental approval from the US health regulator for Yesintek prefilled autoinjector. Yesintek is indicated for the treatment of moderate-to-severe plaque psoriasis and active psoriatic arthritis. The company's subsidiary in the United States has received supplemental US Food and Drug Administration (USFDA) approval for Yesintek of strengths 45 mg/0.5 ml single-dose prefilled autoinjector and 90 mg/ml single-dose prefilled autoinjector, Biocon said in a regulatory filing. Yesintek was originally approved by the USFDA on November 29, 2024, it added. The Yesintek single-dose prefilled autoinjector offers patients with another important treatment option. This new delivery format supports more tailored treatment approaches across different care settings and patient needs, the company said. Yesintek is indicated for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis in adult and pediatric patients

Hence then, the article about biocon arm gets supplemental usfda approval for autoimmune disease drug was published today ( Tuesday 18/08/2026 - 02:28 PM ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Biocon arm gets supplemental USFDA approval for autoimmune disease drug )

Last updated : 18 August 2026 clock 02:28 PM

Also on site :

Biocon arm gets supplemental USFDA approval for autoimmune disease drug ...Middle East

New data shows people are getting personal with AI

Largecaps for stability, mid and smallcap funds for higher returns

First Legal Expands Operations in the Greater NYC Area with Bee Reporting

BWF Worlds: Ashith-Amrutha suffer heartbreak after 71-minute thriller

Pakistan's Power Generation Costs Jump 38% on Record Spot LNG Buys

Jumio Positioned for Third Consecutive Year as the Leader in the 2026 SPARK Matrix™ for Identity Capture and Verification Solutions

Which type of savings account is best for me?

LJM Partners with Clearview Capital to Accelerate Next Phase of Growth

Which credit card is best? The top deals for spending, debt and rewards in August

Godrej Industries to enter pvt credit space, aims to raise ₹2,000 cr in AIF

Houthis Claim Third Attack on Saudi Aramco Refinery in Two Weeks

Rupee fall may reduce effective incentives for semiconductor projects

4Pines Fund Services Appoints Brian Sciortino as Chief Operating Officer

Yiren Digital Upgrades Enterprise AI Across Core Business Functions

U.S. debt set to hit $40 trillion months earlier than expected